血液恶性瘤中外体的近期进展:发病,诊断和治疗策略
Hu Zhang1, Jingyi Xia2, Xueqing Wang1
1Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, People's Republic of China.
International journal of nanomedicine
|November 14, 2024
概括
外体在血液性恶性瘤中至关重要,影响病原和进展. 这些纳米级囊泡具有作为生物标志物和治疗点的潜力,用于治疗白血病和淋巴瘤等癌症.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 纳米医学是一种纳米医学.
背景情况:
- 血液恶性瘤 (淋巴瘤,骨髓瘤,白血病) 是具有高死亡率的侵袭性癌症.
- 尽管取得了进展,但耐药性,耐药性疾病和复发仍然是一个重大挑战.
- 外体,纳米级囊泡参与细胞间通信,越来越多地被认为是它们在这些癌症中的作用.
研究的目的:
- 审查外体在血液性恶性瘤的发病和进展中的多方面的作用.
- 探索外体的潜力作为诊断和预后生物标志物.
- 讨论外体细胞在治疗这些癌症中的治疗应用.
主要方法:
- 关于在血液性恶性瘤中调查外体的研究的文献综述.
- 对外体组合 (蛋白质,脂质,核酸) 和功能进行分析.
- 基于外体细胞的诊断和治疗策略的评估.
主要成果:
- 外体细胞调解关键的病理过程,包括血管生成,增殖,转移,免疫调节和耐药性.
- 外体组件显示为诊断,治疗敏感性和预后的生物标志物具有前途.
- 外体细胞可以作为治疗点,药物输送载体和抗瘤疫苗的组件.
结论:
- 外体在血液性恶性瘤的发展和进展中发挥着关键作用.
- 外体代表了在瘤学中新型诊断和治疗策略的有希望的途径.
- 对外体生物学的进一步研究和应用对于改善患者的治疗结果至关重要.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Bone Marrow Sampling and Transplants
286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


